Sanofi launches Jevtana in UK
July 6, 2011Sales and Marketing Jevtana, Sanofi, prostate cancer
Sanofi has launched its promising advanced prostate cancer drug Jevtana in the UK following EMA approval in March. Jevtana (cabazitaxel) …
GSK changes the way its US sales reps are assessed
July 6, 2011Sales and Marketing GSK, pharma sales force
GlaxoSmithKline has revealed a new way of assessing its US sales representatives’ performance in a bid to make the manufacturer’s …
Sanofi to research new types of antibiotics
July 6, 2011Research and Development Antibiotics, Rib-X Pharmaceuticals, Sanofi, research and development news
Sanofi has signed a research collaboration with Rib-X Pharmaceuticals to investigate new types of antibiotics. The French pharma company has …
Contract research news in brief
July 6, 2011Research and Development CIToxLAB, Jubilant, PupPharma, Quintiles, Toxikon, research and development news
Quintiles helps fund Alzheimer’s drug programme, Toxikon starts building a new facility, plus updates from Jubilant, CIToxLAB and PupPharma. Quintiles …
Study claims cardiovascular risk to Pfizer’s Champix
July 6, 2011Research and Development, Sales and Marketing Champix, Chantix, Pfizer, smoking cessation
Pfizer has been drawn into a war of words over its smoking cessation drug Champix after a review of existing …
Digital Pharma: Bayer tweets breach ABPI Code of Practice
July 5, 2011Medical Communications Bayer, Code of Practice, Digital Pharma blog, PMCPA, Twitter, medical communications news, social media
Bayer’s use of Twitter has caused the first social media breach of the ABPI Code of Practice. Code regulator the …
Merck to close one facility, boosts another
July 5, 2011Manufacturing and Production, Research and Development Ireland, Merck & Co, pharma job cuts, pharma manufacturing news
Merck & Co continues to shake up its network of facilities, deciding to close a recently-acquired site in the USA …
Afinitor stops tumour growth in advanced breast cancer
July 5, 2011Manufacturing and Production, Research and Development Afinitor, Novartis, Votubia, advanced breast cancer
Novartis’ Afinitor has impressed in a late-stage trial by increasing survival in women with advanced breast cancer. The phase III …
SCM Pharma appoints Adam Sims
July 5, 2011Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development
Sterile filling specialist SCM Pharma has bolstered its senior management team with the appointment of Adams Sims as a non-executive …
Pfizer re-acquires Rouses Point from Akrimax
July 5, 2011Manufacturing and Production Pfizer, pharma manufacturing news
Pfizer has decided to buy back a manufacturing facility in Rouses Point, New York, from current owner Akrimax Pharmaceuticals, and …
US team make human ‘biocollagen’ in plants
July 5, 2011Manufacturing and Production collegen, cosmetic surgery, manufacturing and production news, pharma manufacturing news
A team of researchers in the USA have successfully synthesised human collagen in transgenic maize seeds, offering a potential alternative …
EMA publishes details of new pharmacovigilance format
July 4, 2011Research and Development, Sales and Marketing EMA, pharmacovigilance
Pharma companies have been given the highly-specific electronic formats in which they will soon have to submit information on medicines …
A bigger conversation: taking market research online
July 4, 2011Medical Communications, Sales and Marketing digital, market research
The debate around pharma’s use of digital media has tended to focus on building relationships with patients or healthcare professionals …
Xarelto receives FDA approval
July 4, 2011Sales and Marketing Bayer, Eliquis, Johnson & Johnson, Pradaxa, Xarelto, anticoagulant
Bayer and Johnson & Johnson’s oral blood thinner Xarelto has been approved in the US for the prevention of deep …
Nycomed gains new European licence for cancer pain spray
July 4, 2011Sales and Marketing Nycomed, cancer pain, pain therapeutics
The European Commission has approved Nycomed’s Instanyl in a single-dose nasal spray for the treatment of breakthrough pain in cancer …
Reckitt Benckiser promotes Camillo Pane
July 4, 2011Sales and Marketing appointment, sales and marketing
Reckitt Benckiser’s UK general manager Camillo Pane has been promoted to senior vice president – global category officer healthcare. Reporting …
Digital Pharma: The Best of Health in digital
July 1, 2011Medical Communications Best of Health, Digital Pharma blog, awards, digital marketing, medical communications news
Recognition for digital pharma marketing has been slowly increasing over the last couple of years and last night’s Best of …
Lilly prepares late-stage pipeline boost
July 1, 2011Research and Development, Sales and Marketing autoimmune diseases, diabetes, lilly, neuroscience, oncology
Eli Lilly has highlighted diabetes, oncology, autoimmune diseases and neuroscience as key therapy areas within its growth strategy. Within these …
EMA extends Avastin breast cancer licence
July 1, 2011Sales and Marketing avastin, breast cancer, metastatic breast cancer
The EMA has extended the breast cancer licence for Roche’s Avastin after initially restricting the drug’s use. The decision comes …
Red Door promotes Katy Pogson
July 1, 2011Medical Communications appointment, medical communications
Katy Pogson has been promoted to associate director at Red Door Communications and joins its management team. She started at …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
